Back
Attovia Therapeutics, Inc. ATTO · Insights
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases u... Price15.96
Market Cap728.59 M
Float28.44 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro